Program Chair: Roger Barker, UK, Clinical Committee
Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke's Hospital Cambridge. He is a guest professor at the University of Lund, Sweden and a PI in the MRC-Wellcome Trust Stem Cell Institute in Cambridge.

For the last 25 years he has run research that seeks to better define the clinical heterogeneity of two common neurodegenerative disorders of the CNS- namely Parkinson's (PD) and Huntington's disease (HD). This has helped him define the best way by which to take new therapies into the clinic. In this respect he has been heavily involved in gene and cell based trials for patients with PD and currently co-ordinates an EU funded transplant programme using human fetal tissue for patients with PD .

He is part of an EU project (NeuroStemCellRepair) and a global initiative (GFORCE-PD) that is seeking to take stem cells to trial in these disorders. He is currently is Co-Editor in Chief of the Journal of Neurology and has just stepped down from the research advisory board of the Cure PD Trust but is still involved with research strategy with Parkinson's UK. He is a Director and also chairman of the Clinical Translation Committee of the International Society for Stem Cell Research (ISSCR). He has published over 400 papers and is heavily involved in taking science out to the public and in patient engagement.



Membership Software Powered by YourMembership  ::  Legal